SEARCH

SEARCH BY CITATION

References

  • 1
    Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 2002; 324: 7186.
  • 2
    Weil J, Colin-Jones D, Langman M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. Br Med J 1995; 310: 82730.
  • 3
    CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 132939.
  • 4
    Aalykke C, Lauritsen K. Epidemiology of NSAID-related gastroduodenal mucosal injury. Best Pract Res Clin Gastroenterol 2001; 15: 70522.
  • 5
    Liu L, Turner JR, Yu Y, et al. Differential expression of EGFR during the early reparative phase of the gastric mucosa between young and aged rats. Am J Physiol 1998; 275: G94350.
  • 6
    Cryer B, Redfern S, Goldschmiedt M, Lee E, Feldman M. Effect of aging on gastric and duodenal mucosal prostaglandin concentrations in humans. Gastroenterology 1992; 102: 111823.
  • 7
    Santolaria S, Lanas A, Benito R, Perez-Aisa MA, Montoro M, Sainz R. Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users. Aliment Pharmacol Ther 1999; 13: 15118.
  • 8
    Hudson N, Balsitis M, Filipowicz F, Hawkey CJ. Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut 1993; 34: 74851.
  • 9
    Feldman M, Cryer B, Mallat D, Go MF. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial. Am J Gastroenterol 2001; 96: 17517.
    Direct Link:
  • 10
    Pilotto A, Leandro G, Di Mario F, et al. Role of Helicobacter pylori infection on upper gastrointestinal bleeding in the elderly: a case-control study. Dig Dis Sci 1997; 42: 58691.
  • 11
    Liu N-J, Lee C-S, Tang J-H, et al. Outcomes of bleeding peptic ulcers: a prospective study. J Gastroenterol Hepatol 2008; 23: e3407.
  • 12
    Lanas A, Fuentes J, Benito R, Serrano P, Bajador E, Sainz R. Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin. Aliment Pharmacol Ther 2002; 16: 77986.
  • 13
    Piazuelo E, Fuentes J, Garcia-Gonzalez MA, Jimenez P, Lanas A. A case-control study of the association between polymorphisms of the endothelial nitric oxide synthase and glycoprotein IIIa genes and upper gastrointestinal bleeding in users of low-dose aspirin. Clin Ther 2008; 30: 12130.
  • 14
    Ootani H, Iwakiri R, Shimoda R, et al. Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan. J Gastroenterol 2006; 41: 416.
  • 15
    Nakayama M, Iwakiri R, Hara M, et al. Low-dose aspirin is a prominent cause of bleeding ulcers in patients who underwent emergency endoscopy. J Gastroenterol 2009; 44: 9128.
  • 16
    Adamopoulos A, Efstathiou S, Tsioulos D, Tsami A, Mitromaras A, Mountokalakis T. Acute upper gastrointestinal bleeding: comparison between recent users and nonusers of nonsteroidal anti-inflammatory drugs. Endoscopy 2003; 35: 32732.
  • 17
    Nakashima S, Arai S, Mizuno Y, et al. A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2005; 21(Suppl 2): 606.
  • 18
    Tsesmeli NE, Kotsaftis PS, Savopoulos CG, et al. Incidence and etiology of acute non-malignant upper gastrointestinal bleeding in northern Greece. J Gastroenterol Hepatol 2007; 22: 100913.
  • 19
    Ng TM, Fock KM, Khor JL, et al. Non-steroidal anti-inflammatory drugs, Helicobacter pylori and bleeding gastric ulcer. Aliment Pharmacol Ther 2000; 14: 2039.
  • 20
    Akhtar AJ, Shaheen M. Upper gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs in African-American and Hispanic elderly patients. Ethn Dis 2003; 13: 52833.
  • 21
    Pilotto A, Franceschi M, Leandro G, et al. The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs. Aging Clin Exp Res 2003; 15: 4949.
  • 22
    Pilotto A, Franceschi M, Leandro G, Longo MG, Perri F, Scarcelli C. Helicobacter pylori infection and the risk of gastro-duodenal damage in symptomatic elderly chronic low-dose aspirin users: effect of antisecretory drugs. Age Ageing 2004; 33: 4024.
  • 23
    Serrano P, Lanas A, Arroyo MT, Ferreira IJ. Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases. Aliment Pharmacol Ther 2002; 16: 194553.
  • 24
    Chan FKL, Chung SCS, Suen BY, et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 2001; 344: 96773.
  • 25
    Dowlatshahi S, Ghofrani H, Togha M, Dowlatshahi S. Secondary prevention of upper gastrointestinal bleeding in low dose aspirin users infected with Helicobacter pylori. Med J Islam Repub Iran 2005; 19: 356.
  • 26
    Campbell CL, Smyth S, Montalescot G, Steinhubl S. Aspirin dose for the prevention of cardiovascular disease. JAMA 2007; 297: 201824.
  • 27
    Kawai T, Yamagishi T, Goto S. Circadian variations of gastrointestinal mucosal damage detected with transnasal endoscopy in apparently healthy subjects treated with low-dose aspirin (ASA) for a short period. J Atheroscler Thromb 2009; 16: 15563.
  • 28
    Lanas A, Scheiman J. Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment. Curr Med Res Opin 2007; 23: 16373.